P61 SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry

INTRODUCTION/BACKGROUND: There is a lack of data on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination safety in children and young people (CYP) with rheumatic and musculoskeletal diseases (RMDs) as they were excluded from initial vaccine trials. Vaccination guidance is based o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawson-Tovey, Saskia, Machado, Pedro, Strangfeld, Anja, Mateus, Elsa, Gossec, Laure, Carmona, Loreto, Raffeiner, Bernd, Bulina, Inita, Clemente, Daniel, Zepa, Julija, Rodrigues, Ana, Mariette, Xavier, Hyrich, Kimme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515853/
http://dx.doi.org/10.1093/rap/rkac067.061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515853/
http://dx.doi.org/10.1093/rap/rkac067.061

Ejemplares similares